These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8409700)

  • 1. Anthracycline toxicity is potentiated by iron and inhibited by deferoxamine: studies in rat heart cells in culture.
    Hershko C; Link G; Tzahor M; Kaltwasser JP; Athias P; Grynberg A; Pinson A
    J Lab Clin Med; 1993 Sep; 122(3):245-51. PubMed ID: 8409700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of iron loading on transmembrane potential, contraction, and automaticity of rat ventricular muscle cells in culture.
    Link G; Athias P; Grynberg A; Pinson A; Hershko C
    J Lab Clin Med; 1989 Jan; 113(1):103-11. PubMed ID: 2909644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of iron in the potentiation of anthracycline cardiotoxicity: identification of heart cell mitochondria as a major site of iron-anthracycline interaction.
    Link G; Tirosh R; Pinson A; Hershko C
    J Lab Clin Med; 1996 Mar; 127(3):272-8. PubMed ID: 9273360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the topoisomerase II-inactive bisdioxopiperazine ICRF-161 as a protectant against doxorubicin-induced cardiomyopathy.
    Martin E; Thougaard AV; Grauslund M; Jensen PB; Bjorkling F; Hasinoff BB; Tjørnelund J; Sehested M; Jensen LH
    Toxicology; 2009 Jan; 255(1-2):72-9. PubMed ID: 19010377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide and oxidative stress in brain and heart of normal rats treated with doxorubicin: role of aminoguanidine.
    Abd El-Gawad HM; El-Sawalhi MM
    J Biochem Mol Toxicol; 2004; 18(2):69-77. PubMed ID: 15122648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desferal inhibits breast tumor growth and does not interfere with the tumoricidal activity of doxorubicin.
    Hoke EM; Maylock CA; Shacter E
    Free Radic Biol Med; 2005 Aug; 39(3):403-11. PubMed ID: 15993339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart cells in culture: a model of myocardial iron overload and chelation.
    Link G; Pinson A; Hershko C
    J Lab Clin Med; 1985 Aug; 106(2):147-53. PubMed ID: 4020242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of chronic anthracycline cardiotoxicity in the adult Fischer 344 rat by dexrazoxane and effects on iron metabolism.
    Cusack BJ; Gambliel H; Musser B; Hadjokas N; Shadle SE; Charlier H; Olson RD
    Cancer Chemother Pharmacol; 2006 Oct; 58(4):517-26. PubMed ID: 16555089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of aminoguanidine against cardiovascular toxicity of chronic doxorubicin treatment in rats.
    Mostafa AM; Nagi MN; Al Rikabi AC; Al-Shabanah OA; El-Kashef HA
    Res Commun Mol Pathol Pharmacol; 1999; 106(3):193-202. PubMed ID: 11485049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of adriamycin and daunorubicin myocardial toxicity by adenosine.
    Newman RA; Hacker MP; Krakoff IH
    Cancer Res; 1981 Sep; 41(9 Pt 1):3483-8. PubMed ID: 7260911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in gene expression with iron loading and chelation in cardiac myocytes and non-myocytic fibroblasts.
    Parkes JG; Liu Y; Sirna JB; Templeton DM
    J Mol Cell Cardiol; 2000 Feb; 32(2):233-46. PubMed ID: 10722800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iron is not involved in oxidative stress-mediated cytotoxicity of doxorubicin and bleomycin.
    Kaiserová H; den Hartog GJ; Simůnek T; Schröterová L; Kvasnicková E; Bast A
    Br J Pharmacol; 2006 Dec; 149(7):920-30. PubMed ID: 17031387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-permeable superoxide dismutase and glutathione peroxidase mimetics afford superior protection against doxorubicin-induced cardiotoxicity: the role of reactive oxygen and nitrogen intermediates.
    Konorev EA; Kennedy MC; Kalyanaraman B
    Arch Biochem Biophys; 1999 Aug; 368(2):421-8. PubMed ID: 10441396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthracycline-induced cardiac injury using a cardiac cell line: potential for gene therapy studies.
    L'Ecuyer T; Horenstein MS; Thomas R; Vander Heide R
    Mol Genet Metab; 2001 Nov; 74(3):370-9. PubMed ID: 11708868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy.
    Minotti G; Ronchi R; Salvatorelli E; Menna P; Cairo G
    Cancer Res; 2001 Dec; 61(23):8422-8. PubMed ID: 11731422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deferoxamine-induced iron mobilization and redistribution of myocardial iron in cultured rat heart cells: studies of the chelatable iron pool by electron microscopy and Mössbauer spectroscopy.
    Shiloh H; Iancu TC; Bauminger ER; Link G; Pinson A; Hershko C
    J Lab Clin Med; 1992 Apr; 119(4):428-36. PubMed ID: 1583395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of pyrroline and pyrrolidine nitroxides on lipid peroxidation in heart tissue of rats treated with doxorubicin.
    Koceva-Chyła A; Gwoździński K; Kochman A; Stolarska A; Jóźwiak Z
    Cell Mol Biol Lett; 2003; 8(1):179-83. PubMed ID: 12655372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration.
    Saad SY; Najjar TA; Alashari M
    J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron chelation by clinically relevant anthracyclines: alteration in expression of iron-regulated genes and atypical changes in intracellular iron distribution and trafficking.
    Xu X; Sutak R; Richardson DR
    Mol Pharmacol; 2008 Mar; 73(3):833-44. PubMed ID: 18029550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of iron and iron chelators in anthracycline cardiotoxicity.
    Hershko C; Link G; Tzahor M; Pinson A
    Leuk Lymphoma; 1993 Oct; 11(3-4):207-14. PubMed ID: 8260895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.